How big is the Oral Thin Films Market?

The Oral Thin Films Market size is expected to reach USD 3.01 billion in 2024 and grow at a CAGR of 9.56% to reach USD 4.75 billion by 2029. Read More

What is the current Oral Thin Films Market size?

In 2024, the Oral Thin Films Market size is expected to reach USD 3.01 billion. Read More

Who are the key players in Oral Thin Films Market?

ZIM Laboratories Limited, Aquestive Therapeutics, Inc., IntelGenx Corp., C.L.Pharm and CURE Pharmaceutical are the major companies operating in the Oral Thin Films Market. Read More

Which is the fastest growing region in Oral Thin Films Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oral Thin Films Market?

In 2024, the North America accounts for the largest market share in Oral Thin Films Market. Read More

What years does this Oral Thin Films Market cover, and what was the market size in 2023?

In 2023, the Oral Thin Films Market size was estimated at USD 2.72 billion. The report covers the Oral Thin Films Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oral Thin Films Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oral Thin Films Market Share

Statistics for the 2023 & 2024 Oral Thin Films market share, created by Mordor Intelligence™ Industry Reports. Oral Thin Films share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Oral Thin Films Industry

The oral thin films market is moderately competitive and consists of several market players. Companies are engaging in rapid product developments and launches to maximize their market shares. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Aquestive Therapeutics Inc., IntelGenx Corp., C.L. Pharm, CURE Pharmaceutical, and ZIM Laboratories Limited.